Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomson Hallmark

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Methods in Enzymology|March 22, 2025
Purification and in vivo, cell-free, and in vitro characterization of CRISPR-Cas12a2Friso T Schut, Thomson Hallmark, Oleg Dmytrenko, et al.
Micropublication Biology|June 24, 2024
The N-terminal domain of Type IV-A1 CRISPR-associated DinG is vulnerable to proteolysisThomson Hallmark, Andrew A Williams, Olivine Redman, et al.
Micropublication Biology|May 24, 2022
A yeast model for trichohepatoenteric syndrome suggests strong loss of Ski2 function in most causative mutationsLuisa J Orlando, Matthew K Yim, Thomson Hallmark, et al.
Frontiers in Microbiology|June 7, 2021
Positioning Diverse Type IV Structures and Functions Within Class 1 CRISPR-Cas SystemsHannah N Taylor, Eric Laderman, Matt Armbrust, et al.
Nature|January 4, 2023
RNA targeting unleashes indiscriminate nuclease activity of CRISPR-Cas12a2Jack P K Bravo, Thomson Hallmark, Bronson Naegle, et al.
Biorxiv : the Preprint Server for Biology|June 5, 2026
Target RNA-triggered CRISPR-Cas12a2 Preferentially Cleaves Collateral DNA over RNASobita Kunwar, Thomson Hallmark, Sudeshna Manna, et al.
Nucleic Acids Research|June 16, 2026
Target RNA-triggered CRISPR-Cas12a2 preferentially cleaves collateral DNA over RNASobita Kunwar, Thomson Hallmark, Sudeshna Manna, et al.
Nature|January 4, 2023
Cas12a2 elicits abortive infection through RNA-triggered destruction of dsDNAOleg Dmytrenko, Gina C Neumann, Thomson Hallmark, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Methods in Enzymology|March 22, 2025
Purification and in vivo, cell-free, and in vitro characterization of CRISPR-Cas12a2Friso T Schut, Thomson Hallmark, Oleg Dmytrenko, et al.
Micropublication Biology|June 24, 2024
The N-terminal domain of Type IV-A1 CRISPR-associated DinG is vulnerable to proteolysisThomson Hallmark, Andrew A Williams, Olivine Redman, et al.
Micropublication Biology|May 24, 2022
A yeast model for trichohepatoenteric syndrome suggests strong loss of Ski2 function in most causative mutationsLuisa J Orlando, Matthew K Yim, Thomson Hallmark, et al.
Frontiers in Microbiology|June 7, 2021
Positioning Diverse Type IV Structures and Functions Within Class 1 CRISPR-Cas SystemsHannah N Taylor, Eric Laderman, Matt Armbrust, et al.
Nature|January 4, 2023
RNA targeting unleashes indiscriminate nuclease activity of CRISPR-Cas12a2Jack P K Bravo, Thomson Hallmark, Bronson Naegle, et al.
Biorxiv : the Preprint Server for Biology|June 5, 2026
Target RNA-triggered CRISPR-Cas12a2 Preferentially Cleaves Collateral DNA over RNASobita Kunwar, Thomson Hallmark, Sudeshna Manna, et al.
Nucleic Acids Research|June 16, 2026
Target RNA-triggered CRISPR-Cas12a2 preferentially cleaves collateral DNA over RNASobita Kunwar, Thomson Hallmark, Sudeshna Manna, et al.
Nature|January 4, 2023
Cas12a2 elicits abortive infection through RNA-triggered destruction of dsDNAOleg Dmytrenko, Gina C Neumann, Thomson Hallmark, et al.
Pageof 1